Arkolith/Insider Trading/CASI/Form 4

Huang James

DirectorCASI Pharmaceuticals, Inc. (CASI) · full profile →Form 4 · filed Aug 23, 2022
Net Buying
Open-Market Buys
$779K
Open-Market Sells
$0
Net Open-Market Flow
$779K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 23, 2022Buy(P)40K$3.50$140K234K
Aug 22, 2022Buy(P)23K$3.46$80K194K
Aug 19, 2022Buy(P)171K$3.27$560K171K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-029564) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML